Qiu Wang, PhD

Research in the Wang group aims to answer fundamental questions that lie at the interface of chemistry and biology. We develop small-molecule based probes and methods to understand genes and pathways of importance to the treatment of neurodegenerative disorders. To this end, we use an interdisciplinary approach that integrates the principles of synthetic chemistry, assay development, molecular and cell biology, genetics and proteomics (the large-scale study of proteins) through our studies in the areas of bioactive molecule probes in human biology and disease,  epigenetic  modifying  enzymes  as  novel therapeutic targets and new chemical tools for biomolecule labeling  and  target identification.